Therefore, to mitigate the impact of these confounding factors, it is imperative to closely monitor the basal level of patients and track the fluctuations in adiponectin levels throughout the sepsis stage, rather than solely relying on a “reference range” for assessing sepsis status and patient condition. This evidence concerns the gene ADIPOQ and Sepsis.